Seroprotection Status of Hepatitis B Vaccine in Children with Type 1 Diabetes Mellitus

Código QR

Seroprotection Status of Hepatitis B Vaccine in Children with Type 1 Diabetes Mellitus

Background:"Type 1 diabetes mellitus [T1DM]" is the most common endocrine disease in the Pediatric population. It has been suggested that T1DM had inadequate immunological response to vaccines, including hepatitis B virus [HBV] vaccine. Aim of the Work:To evaluate the immunological status...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dina Elsharkawy, Hany Abd Elhady El-khaleegy, Saad Mohamed, Gamal Mohamed
Formato:	article
Lenguaje:	EN
Publicado:	Al-Azhar University, Faculty of Medicine (Damietta) 2021
Materias:	seroprotection hepatitis b vaccine type-1 diabetes mellitus Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/bd25e20f301749aaa7ddd3b95d8ead09
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

COMPARING HEPATITIS B SEROPROTECTION IN PAKISTANI CHILDREN AT 5 AND 6 YEARS OF AGE AFTER EXPANDED PROGRAMME ON IMMUNIZATION (EPI) VACCINATION
por: Ehsan Qadir, et al.
Publicado: (2020)

IMMUNOGENICITY OF THE THIRD GENERATION HEPATITIS B VACCINE (pre-S1/pre-S2/S)
por: E. V. Esaulenko, et al.
Publicado: (2018)

Hepatitis B vaccination status and associated factors among university students in Ghana: A cross-sectional survey
por: Akwasi Adjei Gyimah, et al.
Publicado: (2021)

Markers for hepatic autoimmune disorders in patients with type 1 diabetes mellitus
por: Olga Sergeevna Derevyanko, et al.
Publicado: (2014)

Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
por: Percy A. Knolle, et al.
Publicado: (2021)

EPIDEMIOLOGICAL CHARACTERISTICS OF HEPATITIS A INFECTION IN THE PRE-VACCINATION AND VACCINATION PERIODS
por: V. N. Loshkareva, et al.
Publicado: (2014)

Importancia de las vacunas contra los virus de las hepatitis A y B en Chile
por: Valenzuela B,M Teresa
Publicado: (2009)

Cambios en la epidemiología de las hepatitis virales en Chile y consideraciones en estrategias de prevención
por: Ibarra V,Humberto
Publicado: (2007)

Travelers’ vaccines and their adverse events in Nara, Japan
por: Ogawa Taku, et al.
Publicado: (2021)

Inmunogenicidad de una vacuna recombinante anti hepatitis B en personal de salud
por: GARCÍA C.,PATRICIA, et al.
Publicado: (2002)

Surveying children and adult vaccination program against diphtheria, tetanus, measles and viral hepatitis B in the Russian Federation
por: N. P. Galina, et al.
Publicado: (2020)

Immune Response in Preterm Infants to Hepatitis B Vaccine
por: Y Zahedpasha, et al.
Publicado: (2011)

Hepatitis A Outbreak Characteristics: A Comparison of Regions with Different Vaccination Strategies, Spain 2010–2018
por: Angela Domínguez, et al.
Publicado: (2021)

Vaccination and diabetes mellitus type 1 in children
por: Alisa V. Vitebskaya, et al.
Publicado: (2018)

Estimación del impacto de la infección por Hepatitis A en zonas urbanas de Colombia 2008: Un análisis a partir de datos secundarios
por: ALVIS,NELSON, et al.
Publicado: (2010)

IS IT NECESSARY TO VACCINATE CHILDREN AGAINST HEPATITIS A ROUTINELY IN PRESENT TIME? THE EVALUATION OF RESULTS OF SUCH STRATEGY OF HEPATITIS A VACCINE PROPHYLAXIS IN SELECTED REGIONS OF THE RUSSIAN FEDERATION
por: I. V. Shakhgildian, et al.
Publicado: (2014)

Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
por: Vicente Soriano, et al.
Publicado: (2022)

Comparison of the effect of Hepatitis B vaccination in normal and low birth weight neonates
por: MR Esmaili Duki, et al.
Publicado: (2003)

Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
por: Sheikh Mohammad Fazle Akbar, et al.
Publicado: (2021)

Epidemiología de la hepatitis B en Chile y esquemas de vacunación en Latinoamérica
por: ZUNINO M.,ENNA
Publicado: (2002)

EPIDEMIOLOGICAL SURVEILLANCE OF VIRAL HEPATITIS A ON THE TERRITORY OF THE REPUBLIC OF BURYATIA
por: G. S. Amagzayeva, et al.
Publicado: (2012)

Response to Hepatitis B vaccination in health care workers of Yahyanejad Hospital, Babol, 2002
por: M Kashi Fard, et al.
Publicado: (2004)

Gating strategy for plasmablast enumeration after hepatitis B vaccination
por: M. G. Byazrova, et al.
Publicado: (2021)

Assessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy
por: Izabela Szczygielska, et al.
Publicado: (2020)

Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination
por: Hamad Ali, et al.
Publicado: (2021)

Hepatitis crónica por virus C: factores asociados a la severidad del daño histológico
por: Orellana N,Ivonne, et al.
Publicado: (2005)

Vacuna anti hepatitis A
por: COFRÉ G.,JOSÉ, et al.
Publicado: (2003)

Relation between Iron Status and Hemoglobin A1c in Children with Type-1 Diabetes Mellitus
por: Fatma El Nezely, et al.
Publicado: (2021)

Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study
por: Yoshihiro Inoue, et al.
Publicado: (2021)

Infectious diseases in the era of refugees: Hepatitis A outbreak in Lebanon
por: Abdul Rahman Bizri, et al.
Publicado: (2018)

A Cross-sectional Study on Hepatitis B Vaccination Status and Post-exposure Prophylaxis Practices Among Health Care Workers in Teaching Hospitals of Mangalore
por: H.N. Harsha Kumar, et al.
Publicado: (2016)

Approaches to vaccine prophilaxis of respiratory infections in patients with diabetes mellitus in the modern epidemiological situation
por: Alla A. Tarasova, et al.
Publicado: (2019)

Comorbid hepatitis C does not modulate prevalence or severity of diabetic retinopathy
por: Koenig LR, et al.
Publicado: (2019)

Immune response to hepatitis B vaccine following complete immunization of children attending two regional hospitals in the Southwest region of Cameroon: a cross sectional study
por: Ephesians N. Anutebeh, et al.
Publicado: (2021)

The response to Hepatitis B virus vaccine in HIV-infected patients (HIV/AIDS counseling and care center in Kermanshah)
por: K Alaei, et al.
Publicado: (2004)

Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
por: Kadhim Hayawi, et al.
Publicado: (2021)

Distribution of Hepatic Myofibroblasts and Type I and III Collagen in Rat Liver Cirrhosis Induced by Thioacetamide
por: Poonkhum,Raksawan, et al.
Publicado: (2011)

Association between maternal hepatitis B virus carrier and gestational diabetes mellitus: a retrospective cohort analysis
por: Wanchang Yin, et al.
Publicado: (2021)

MODERN STATUS OF VACCINE PROPHYLAXIS OF MUMPS
por: E. O. Kontarova, et al.
Publicado: (2014)

Enfermedades autoinmunitarias asociadas a diabetes mellitus tipo 1A
por: Ferreira-Hermosillo,Aldo, et al.
Publicado: (2015)